CMS issued Medicare Part D coverage guidance stating that in instances when an obesity medication receives approval for an additional medically accepted indication during the contract year, Part D sponsors may include such drugs on their current Part D formularies. That means Medicare Part D plans can begin covering tirzepatide for OSA without waiting for the next plan year
With diabesity affecting millions worldwide, the drug offers hope for improved quality of life and reduced risk of complications such as cardiovascular disease, kidney failure, and neuropathy
Aroda VR, Bauer R, Hertz CL, et al
This produces a steric hindrance that prevents AA from being metabolized
3 Get your prescription Well send your Zepbound prescription to your preferred pharmacy for pick up and assist with any applicable insurance approvals
What You Receive A standard 4-week supply of Tirzeparo 7.5mg